LC/MS/MS method for analysis of E2 series prostaglandins and isoprostanes

Journal of Lipid Research

Volumn 52, Issue 4, 2011, Pages 850-859

  Brose, Stephen A ^a   Thuen, Brock T ^a   Golovko, Mikhail Y ^a  

^a UNIVERSITY OF NORTH DAKOTA   (United States)

Author keywords

Brain lipids; High performance liquid chromatography; Ischemia; Isoprostane; Microwave irradiation; Phospholipid; Prostaglandin; Prostanoid analysis; Tandem mass spectrometry

Indexed keywords

9 OXO 11ALPHA,15 DIHYDROXY (8BETA)PROSTA 5,13 DIEN 1 OIC ACID; 9 OXO 11BETA,15 DIHYDROXY (18BETA,12ALPHA)PROSTA 5,13 DIEN 1 OIC ACID; 9 OXO 11BETA,15 DIHYDROXYPROSTA 5,13 DIEN 1 OIC ACID; 9ALPHA,15 DIHYDROXY 11 OXO PROSTA 5,13 DIEN 1 OIC ACID; ISOPROSTANE DERIVATIVE; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN E2 DERIVATIVE; UNCLASSIFIED DRUG;

ACCURACY; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CALIBRATION; CHIRAL CHROMATOGRAPHY; CONTROLLED STUDY; ESTERIFICATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY; MALE; MICROWAVE IRRADIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, LIQUID; DINOPROSTONE; ISOPROSTANES; MALE; MICE; MOLECULAR STRUCTURE; TANDEM MASS SPECTROMETRY;

EID: 79953305096     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.D013441     Document Type: Article

References (50)

1. Phillis, J. W., L. A. Horrocks, and A. A. Farooqui. 2006. Cycloxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders. Brain Res. Rev. 52: 201-243.
2. Bazan, N. G., V. Colangelo, and W. J. Lukiw. 2002. Prostaglandins and other lipid mediators in Alzheimer's disease. Prostaglandins Other Lipid Mediat. 68-69: 197-210.
3. Chen, C., and N. G. Bazan. 2005. Lipid signaling: sleep, synaptic plasticity, and neuroprotection. Prostaglandins Other Lipid Mediat. 77: 65-76.
4. Minghetti, L., and M. Pocchiari. 2007. Cyclooxygenase-2, prostaglandin E 2, and microglial activation in prison diseases. Int. Rev. Neurobiol. 82: 265-275.
5. Wolfe, L. S. 1982. Eicosanoids: prostaglandins, thromboxanes, leukotrienes, and other derivatives of carbon-20 unsaturated fatty acids. J. Neurochem. 38: 1-14. (Pubitemid 12189188)
6. Demediuk, P., R. D. Saunders, D. K. Anderson, E. D. Means, and L. A. Horrocks. 1985. Membrane lipid changes in laminectomized and traumatized cat spinal cord. Proc. Natl. Acad. Sci. USA. 82: 7071-7075.
7. Murphy, E. J., D. L. Behrmann, C. M. Bates, and L. A. Horrocks. 1994. Lipid alterations following impact spinal cord trauma in the rat. Mol. Chem. Neuropathol. 23: 13-26.
8. Backlund, M. G., J. R. Mann, and R. N. DuBois. 2005. Mechanisms for the prevention of gastrointestinal cancer: the role of prostaglandin E 2. Oncology. 69: 28-32.
9. Hata, A. N., and R. M. Breyer. 2004. Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol. Ther. 103: 147-166.
10. Rocha, P. N., T. J. Plumb, and T. M. Coffman. 2003. Eicosanoids: lipid mediators of inflammation in transplantation. Springer Semin. Immunopathol. 25: 215-227.
11. Patrignani, P., S. Tacconelli, M. G. Schiulli, and M. L. Capone. 2005. New insights into COX-2 biology and inhibition. Brain Res. Brain Res. Rev. 48: 352-359.
12. Rosenberger, T. A., N. E. Villacreses, J. T. Hovda, F. Boestti, G. Weerasinghe, R. N. Wine, G. J. Harry, and S. I. Rapoport. 2004. Rat brain arachidonic acid metabolism is increased by a 6-day intracerebral ventricular infusion of bacterial lipopolysaccharide. J. Neurochem. 88: 1168-1178.
13. Gao, L., W. E. Zackert, J. J. Hasford, M. E. Danekis, G. L. Milne, C. Remmert, J. Reese, H. Yin, H-H. Tai, S. K. Dey, et al. 2003. Formation of prostaglandins E2 and D2 via the isoprostane pathway. J. Biol. Chem. 278: 28479-28489.
14. Morrow, J. D., K. E. Hill, R. F. Burk, T. M. Nammour, K. F. Badr, and L. J. Roberts, Ii. 1990. A series of prostaglandin F 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalized mechanism. Proc. Natl. Acad. Sci. USA. 87: 9383-9387.
15. Morrow, J. D., T. A. Minton, C. R. Mukundan, M. D. Campbell, W. E. Zackert, V. C. Daniel, K. F. Badr, I. A. Blair, and L. J. Roberts, Ii. 1994. Free radical-induced generation of isoprostanes in vivo: evidence for the formation of D-ring and E-ring isoprostanes. J. Biol. Chem. 269: 4317-4326.
16. Rokach, J., S. Kim, S. Bellone, J. A. Lawson, D. Praticò, W. S. Powell, and G. A. FitzGerald. 2004. Total synthesis of isoprostanes: discovery and quantitation in biological systems. Chem. Phys. Lipids. 128: 35-56.
17. Morrow, J. D., J. A. Awad, H. J. Boss, I. A. Blair, and L. J. Roberts, Ii. 1992. Non-cyclooxygenase-derived prostanoids (F 2-isoprostanes) are formed in situ on phospholipids. Proc. Natl. Acad. Sci. USA. 89: 10721-10725.
18. Morrow, J. D. 2006. The isoprostanes-unique products of arachidonate peroxidation: their role as mediators of oxidant stress. Curr. Pharm. Des. 12: 895-902.
19. Morrow, J. D., L. J. Roberts, V. C. Daniel, J. A. Awad, O. Mirochnitchenko, L. L. Swift, and R. F. Burk. 1998. Comparison of formation of D2/E2-isoprostanes and F2-isoprostanesin vitro and in vivo-effects of oxygen tension and glutathione. Arch. Biochem. Biophys. 353: 160-171.
20. Morrow, J. D., J. Scruggs, Y. Chen, W. E. Zackert, and L. J. Roberts II. 1998. Evidence that the E2-isoprostane, 15-E2t-isoprostane (8-isoprostaglandin E2) is formed in vivo. J. Lipid Res. 39: 1589-1593.
21. Longmire, A. W., L. J. Roberts, and J. D. Morrow. 1994. Actions of the E2-isoprostane, 8-ISO-PGE2, on the platelet thromboxane/endoperoxide receptor in humans and rats: additional evidence for the existence of a unique isoprostane receptor. Prostaglandins. 48: 247-256.
22. Roberts II, L. J., and G. L. Milne. 2009. Isoprostanes. J. Lipid Res. 50: S219-S223.
23. Milne, G. L., H. Yin, J. D. Brooks, S. Sanchez, L. Jackson Roberts Ii, and J. D. Morrow. 2007. Quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress. In Methods in Enzymology. H. A. Brown, editor. Academic Press. 113-126.
24. Stafforini, D. M., J. R. Sheller, T. S. Blackwell, A. Sapirstein, F. E. Yull, T. M. McIntyre, J. V. Bonventre, S. M. Prescott, and L. J. Roberts, Ii. 2006. Release of free F 2-isoprostanes from esterified phospholipids is catalyzed by intracellular and plasma platelet-activating factor acetylhydrolases. J. Biol. Chem. 281: 4616-4623.
25. Meyer, M. C., P. Rastogi, C. S. Beckett, and J. McHowat. 2005. Phospholipase A 2 inhibitors as potential anti-inflammatory agents. Curr. Pharm. Des. 11: 1301-1312. (Pubitemid 40458275)
26. Tzeng, S. F., H. Y. Hsiao, and O. T. Mak. 2005. Prostaglandins and cycloxygenases in glial cells during brain inflammation. Curr. Drug Targets Inflamm. Allergy. 4: 335-340.
27. Engblom, D., M. Ek, S. Saha, A. Ericsson-Dahlstrand, P. J. Jakobsson, and A. Blomqvist. 2002. Prostaglandins as inflammatory messengers across the blood-brain barrier. J. Mol. Med. 80: 5-15. (Pubitemid 34143403)
28. Strokin, M., M. Sergeeva, and G. Reiser. 2004. Role of Ca 2+ -independent phospholipase A 2 and n-3 polyunsaturated fatty acid docosahexaenoic acid in prostanoid production in brain: perspectives for protection in neuroinflammation. Int. J. Dev. Neurosci. 22: 551-557. (Pubitemid 39311444)
29. Golovko, M. Y., and E. J. Murphy. 2008. An improved LC-MS/MS procedure for brain prostanoid analysis using brain fixation with head-focused microwave irradiation and liquid-liquid extraction. J. Lipid Res. 49: 893-902.
30. Taylor, A. W., R. S. Bruno, B. Frei, and M. G. Traber. 2006. Benefits of prolonged gradient separation for high-performance liquid chromatography-tandem mass spectrometry quantitation of plasma total 15-series F2-isoprostanes. Anal. Biochem. 350: 41-51.
31. Masoodi, M., and A. Nicolaou. 2006. Lipidomic analysis of twenty-seven prostanoids and isoprostanes by liquid chromatography/electrospray tandem mass spectrometry. Rapid Commun. Mass Spectrom. 20: 3023-3029. (Pubitemid 44569781)
32. Cao, H., L. Xiao, G. Park, X. Wang, A. C. Azim, J. W. Christman, and R. B. van Breemen. 2008. An improved LC-MS/MS method for the quantification of prostaglandins E2 and D2 production in biological fluids. Anal. Biochem. 372: 41-51. (Pubitemid 350103783)
33. Schneider, C., W. E. Boeglin, J. J. Prusakiewicz, S. W. Rowlinson, L. J. Marnett, N. Samel, and A. R. Brash. 2002. Control of prostaglandin stereochemistry at the 15-carbon by cyclooxygenases-1 and -2. A critical role for serine 530 and valine 349. J. Biol. Chem. 277: 478-485.
34. Schmidt, R., O. Coste, and G. Geisslinger. 2005. LC-MS/MS-analysis of prostaglandin E2 and D2 in microdialysis samples of rats. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 826: 188-197. (Pubitemid 41446449)
35. Yang, P., D. Chan, E. Felix, T. Madden, R. D. Klein, I. Shureiqi, X. Chen, A. J. Dannenberg, and R. A. Newman. 2006. Determination of endogenous tissue inflammation profiles by LC/MS/MS: COX- and LOX-derived bioactive lipids. Prostaglandins Leukot. Essent. Fatty Acids. 75: 385-395.
36. Kempen, E. C., P. Yang, E. Felix, T. Madden, and R. A. Newman. 2001. Simultaneous quantification of arachidonic acid metabolites in cultured tumor cells using high-performance liquid chromatography/electrospray ionization tandem mass spectrometry. Anal. Biochem. 297: 183-190.
37. Golovko, M. Y., and E. J. Murphy. 2008. Brain prostaglandin formation is increased by alpha-synuclein gene-ablation during global ischemia. Neurosci. Lett. 432: 243-247.
38. Farias, S. E., M. Basselin, L. Chang, K. A. Heidenreich, S. I. Rapoport, and R. C. Murphy. 2008. Formation of eicosanoids, E2/D2 isoprostanes, and docosanoids following decapitation-induced ischemia, measured in high-energy-microwaved rat brain. J. Lipid Res. 49: 1990-2000.
39. Murphy, R. C., R. M. Barkley, K. Zemski Berry, J. Hankin, K. Harrison, C. Johnson, J. Krank, A. McAnoy, C. Uhlson, and S. Zarini. 2005. Electrospray ionization and tandem mass spectrometry of eicosanoids. Anal. Biochem. 346: 1-42. (Pubitemid 41456623)
40. Brichac, J., A. Honzatko, and M. J. Picklo. 2007. Direct and indirect high-performance liquid chromatography enantioseparation of trans-4-hydroxy-2- nonenoic acid. J. Chromatogr. A. 1149: 305-311.
41. Anton, R. F., C. Wallis, and C. L. Randall. 1983. In vivo regional levels of PGE and thromboxane in mouse brain: effect of decapitation, focused microwave fixation, and indomethacin. Prostaglandins. 26: 421-429.
42. Bosisio, E., C. Galli, G. Galli, S. Nicosia, C. Spagnuolo, and L. Tosi. 1976. Correlation between release of free arachidonic acid and prostaglandin formation in brain cortex cerebellum. Prostaglandins. 11: 773-781.
43. Saenger, A. K., T. J. Laha, M. J. Edenfield, and S. M. H. Sadrzadeh. 2007. Quantification of urinary 8-iso-PGF 2 alpha using liquid chromatography-tandem mass spectrometry and association with elevated troponin levels. Clin. Biochem. 40: 1297-1304.
44. Schneider, C., Z. Yu, W. E. Boeglin, Y. Zheng, A. R. Brash, and H. A. Brown. 2007. Enantiomeric separation of hydroxy and hydroperoxy eicosanoids by chiral column chromatography. In Methods in Enzymology. Academic Press. 145-157.
45. Schneider, C., W. E. Boeglin, and A. R. Brash. 2000. Enantiomeric separation of hydroxy eicosanoids by chiral column chromatography: effect of the alcohol modifier. Anal. Biochem. 287: 186-189.
46. Abdel-Halim, M. S., I. Lunden, G. Cseh, and E. Anggard. 1980. Prostaglandin profiles in nervous tissue and blood vessels of the brain of various animals. Prostaglandins. 19: 249-258. (Pubitemid 10121538)
47. Peters, O., T. Back, U. Lindauer, C. Busch, D. Megow, J. Dreier, and U. Dirnagl. 1998. Increased formation of reactive oxygen species after permanent and reversible middle cerebral artery occlusion in the rat. J. Cereb. Blood Flow Metab. 18: 196-205. (Pubitemid 28082517)
48. Marin, J. G., S. Cornet, B. Spinnewyn, C. Demerlé-Pallardy, M. Auguet, and P. E. Chabrier. 2000. BN 80933 inhibits F2α isoprostane elevation in focal cerebral ischaemia and hypoxic neuronal cultures. Neuroreport. 11: 1357-1360.
49. Sun, G. Y., and R. A. MacQuarrie. 1989. Deacylation-reacylation of arachidonoyl groups in cerebral phospholipids. Ann. N. Y. Acad. Sci. 559: 37-55.
50. Rapoport, S. I. 2003. In vivo approaches to quantifying and imaging brain arachidonic and docosahexaenoic acid metabolism. J. Pediatr. 143: S26-S34. (Pubitemid 37346691)